Reply To: Novavax Soars 80% After COVID-19 Vaccine Funding and Earnings

#49464
Truman
Participant

Novavax priced public offering to sell 6,500,000 shares of its common stock at $10.00/share.
$NVAX 9.82 ▼ -1.50 (-13.21%) today